Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thalidomide and thrombosis].

B Flageul1, D Wallach, B Cavelier-Balloy

  • 1Clinique des Maladies Cutanées, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris Cedex 10, France.

Annales De Dermatologie Et De Venereologie
|March 31, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linear morphea of the penis with 'en coup de sabre' presentation and penile vein thrombosis.

Annales de dermatologie et de venereologie·2025
Same author

Muir-Torre syndrome revealed by sebaceous carcinoma of the scrotum.

Annales de dermatologie et de venereologie·2025
Same author

Vintage descriptions of IgA pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Penoscrotal Paget's disease.

Annales de dermatologie et de venereologie·2021
Same author

A relapsing localized variant of neutrophilic dermatosis triggered by tissue injury.

The British journal of dermatology·2020
Same author

Reactional squamous hyperplasia of the foreskin.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Thalidomide, known for teratogenicity and neuropathy, may also precipitate thrombotic events. This study observed five patients developing thrombosis shortly after starting thalidomide treatment, suggesting a potential link.

Area of Science:

  • Pharmacology
  • Vascular Medicine
  • Immunology

Background:

  • Thalidomide is a medication with known serious side effects including teratogenicity and neuropathy.
  • This case series investigates a potential association between thalidomide initiation and the occurrence of thrombotic events.

Observation:

  • Five patients, four with lupus erythematosus and one with severe atopic dermatitis, developed arterial or venous thrombosis within weeks of starting thalidomide (50-100 mg/day).
  • All patients lacked prior history of vascular events, and four experienced severe thrombotic outcomes.

Findings:

  • Patients presented with thrombosis (2 arterial, 3 venous) shortly after thalidomide initiation, despite no prior history of such events.
  • Identified thrombosis risk factors included antiphospholipid antibodies in lupus patients and trauma in the atopic dermatitis case.

Related Experiment Videos

Implications:

  • The rapid onset and severity of thrombosis post-thalidomide, particularly in patients with existing risk factors, warrant further investigation.
  • Thalidomide's potential pro-thrombotic effects, possibly linked to its impact on angiogenesis, require confirmation in at-risk populations.